{"id":1103,"date":"2025-03-17T10:00:00","date_gmt":"2025-03-17T09:00:00","guid":{"rendered":"https:\/\/www.amypore.com\/publications-scienti\/preclinical-assessment-of-a-ganglioside-targeted-therapy-for-parkinsons-disease-with-the-first-in-class-adaptive-peptide-amyp53\/"},"modified":"2026-09-25T14:15:17","modified_gmt":"2026-09-25T12:15:17","slug":"preclinical-assessment-of-a-ganglioside-targeted-therapy-for-parkinsons-disease-with-the-first-in-class-adaptive-peptide-amyp53","status":"publish","type":"publications-scienti","link":"https:\/\/www.amypore.com\/en\/publications-scienti\/preclinical-assessment-of-a-ganglioside-targeted-therapy-for-parkinsons-disease-with-the-first-in-class-adaptive-peptide-amyp53\/","title":{"rendered":"Preclinical assessment of a ganglioside-targeted therapy for Parkinson\u2019s disease with the first-in-class adaptive peptide AmyP53"},"template":"","class_list":["post-1103","publications-scienti","type-publications-scienti","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.amypore.com\/en\/wp-json\/wp\/v2\/publications-scienti\/1103","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.amypore.com\/en\/wp-json\/wp\/v2\/publications-scienti"}],"about":[{"href":"https:\/\/www.amypore.com\/en\/wp-json\/wp\/v2\/types\/publications-scienti"}],"wp:attachment":[{"href":"https:\/\/www.amypore.com\/en\/wp-json\/wp\/v2\/media?parent=1103"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}